Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Study Director
CONTACT
Lead
Axsome Therapeutics, Inc.
Eligible subjects will be randomized in a 1:1:1 ratio to receive AXS-05, bupropion, or placebo for 12 weeks, followed by an 18-week follow-up period.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
